From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to ...

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

Researchers say early deep brain stimulation and emerging therapies could reshape expectations for patients diagnosed in the ...

Japan's health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma's iPS cell-derived treatment for Parkinson's disease, paving the way for the world's first medical products ...

With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to ...

A Connecticut resident was diagnosed with a life-altering disease almost a year ago and while waiting to be seen at a UConn Health clinic, his wife spotted a flyer about a study that’s seeking a ...

Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS ...

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 million globally, is characterized by debilitating symptoms such as tremors, ...